Australia
April 1. 2021
The Regulator has issued licence DIR 176 to PTM Solutions Australia Pty Ltd, authorising the limited and controlled release (field trial) of white clover genetically modified (GM) for increased condensed tannins.
The Risk Assessment and Risk Management Plan (RARMP) and the licence were finalised taking into account input received during consultation with the public, State and Territory governments, Australian Government agencies, the Minister for the Environment, the Gene Technology Technical Advisory Committee and local councils. The Regulator thanks submitters for their contributions.
Submissions are summarised in Appendix A and Appendix B of the RARMP, together with information about how the issues raised relating to risks to human health and safety or the environment were considered in preparing and finalising the RARMP.
The finalised RARMP concludes that this field trial poses negligible risks to the health and safety of people and the environment, thus it does not require specific risk treatment measures. However, licence conditions have been imposed to limit the size, location and duration of the release and to restrict spread and persistence of the GMOs and their genetic material in the environment, as these were important considerations for the RARMP.
The finalised RARMP, a summary of the RARMP, the licence and Questions and Answers about this decision can be obtained online from the DIR 176 page of the Office of the Gene Technology Regulator’s (OGTR) website or requested via the contacts detailed below. The interactive map showing the locations of field trial sites will be updated on the OGTR website once the GM white clover is planted.
Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601 Tel: 1800 181 030
E-mail: ogtr@health.gov.au
OGTR website
DIR 176 documents
The following documents are available for DIR 176:
Notification of licence decision
Outlines the Regulator’s decision to issue a licence following the assessment of this application.
PDF format - 149 KB
DOCX format - 53 KB
Questions and Answers on licence decision
A series of questions and corresponding answers on the licence application and the Regulator’s decision to issue a licence for this application.
PDF format - 82 KB
DOCX format - 26 KB
Summary of Risk Assessment and Risk Management Plan
The document summarises the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
PDF format - 171 KB
DOCX format - 86 KB
Full Risk Assessment and Risk Management Plan
The document details the risk assessment and risk management plan prepared as part of the Regulator’s decision making process for this application. It explains the risk assessment context, provides an assessment of risks posed by the GMO(s) and details whether any of those risks require management. It also includes a summary of submissions received during the public consultation process.
PDF format - 890 KB
DOCX format - 442 KB
Licence Conditions
The document explains the licence conditions imposed by the Regulator. It provides details of the licence holder’s obligations, including both general conditions required in all licences and specific conditions for this licence, as well as reporting requirements.
PDF format - 566 KB
DOCX format - 259 KB
Reference Material
Risk Analysis Framework for licence applications to the Office of the Gene Technology Regulator (2013)
The biology of Trifolium repens L. (white clover)
Topics
Species
